Meag Munich Ergo Kapitalanlagegesellschaft cut its stake in Abbott Laboratories (NYSE:ABT) by 94.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,600 shares of the healthcare product maker’s stock after selling 224,120 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft’s holdings in Abbott Laboratories were worth $546,000 as of its most recent filing with the SEC.
